Back

Risk stratification and clinical outcomes after pulmonary valve replacement

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Risk stratification in congenital heart disease Diagnostic Methods ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Alexander Egbe

Mayo Clinic, Rochester (United States of America)

7 More presentations in this session

Presentation thumbnail
Repeated measurements of cardiac biomarkers for risk prediction in pulmonary arterial hypertension associated with congenital heart disease: a 10-year observational cohort study
Ms A. van Dissel (Amsterdam, NL)
Abstract
Presentation thumbnail
Development and validation of a risk prediction model in patients with adult congenital heart disease
Ms V. Baggen (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
Prognostic value of echocardiographic and blood biomarkers in patients with a systemic right ventricle
Doctor A. Van Den Bosch (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
Predictors of mortality following hospitalisation in adults with congenital heart disease
Doctor A. Khokhar (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Prognostic value of left ventricular rotation and strain in adult patients with repaired tetralogy of Fallot
Mr R. van Grootel (Rotterdam, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Risk stratification in congenital heart disease

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources